XBIT CIK: 1626878

XBiotech Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
247
FY22:
220
FY23:
202
FY24:
175
FY25:
127
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.3
FY22:
26.3
FY23:
24.9
FY24:
24.5
FY25:
23.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
275
FY22:
246
FY23:
227
FY24:
199
FY25:
150

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.45
FY22:
4.07
FY23:
6.10
FY24:
15.1
FY25:
7.93
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.34
FY22:
1.64
FY23:
1.67
FY24:
1.72
FY25:
1.80
(positive)
Change from FY21 to FY25
millions USD
FY21:
269
FY22:
240
FY23:
219
FY24:
182
FY25:
140
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
275
FY22:
246
FY23:
227
FY24:
199
FY25:
150

All amounts in millions USD Data source:SEC EDGAR